国:ドイツ 取引所:Frankfurt セクター:医療 産業:バイオテクノロジー 株式市場―見積もりと価格
価格、時価総額、PE、EPSを含む全株式と自己資本のリスト
Frankfurt (648)
- {{item.name}}
- 全取引所
- Dusseldorf (1)
- Frankfurt (648)
- Munich (27)
- Stuttgart (39)
- XETRA (23)
バイオテクノロジー (648)
名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 |
---|
名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | |
---|---|---|---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
Sino Biopharmaceutical Limited SMZ1.F | $0.56 0.62 USD |
+3.49
|
$10.44B 11.41B USD | $7.8K 8.53K USD | $0.56 0.62 USD | $0.56 0.62 USD | $10.44B 11.41B USD | 56.30 | $0.01 0.01 USD | |
CureVac N.V. 5CV.F | $4.56 4.99 USD |
-0.83
|
$1.03B 1.13B USD | $12.19K 13.32K USD | $4.56 4.98 USD | $4.62 5.05 USD | $1.03B 1.13B USD | 5.70 | $0.8 0.87 USD | |
Valneva SE AYJ.F | $2.48 2.71 USD |
+0.98
|
$421.42M 460.67M USD | $1.5K 1.64K USD | $2.48 2.71 USD | $2.49 2.72 USD | $421.42M 460.67M USD | 0 | -$0.56 -0.6 USD | |
Ocugen, Inc. 2H51.F | $0.9 0.98 USD |
-4.44
|
$261.54M 285.9M USD | $1.31K 1.43K USD | $0.8699 0.95 USD | $0.9 0.98 USD | $261.54M 285.9M USD | 0 | -$0.17 -0.1 USD | |
Abliva AB (publ) NTP.F | $0.04 0.04 USD |
0
|
$64.47M 70.47M USD | $4K 4.37K USD | $0.02999 0.03 USD | $0.04 0.04 USD | $64.47M 70.47M USD | 0 | -$0.01 -0.01 USD | |
Immunic, Inc. 10VA.F | $0.5899 0.65 USD |
+0.85
|
$58.76M 64.23M USD | $15 16.4 USD | $0.5899 0.65 USD | $0.5899 0.65 USD | $58.76M 64.23M USD | 0 | -$0.81 -0.8 USD | |
Alterity Therapeutics Limited PBN.F | $0.004 0.0043 USD |
0
|
$44.62M 48.78M USD | $480K 524.7K USD | $0.004 0.0043 USD | $0.004 0.0043 USD | $44.62M 48.78M USD | 0 | $0 0 USD | |
Defence Therapeutics Inc. DTC.F | $0.46 0.5 USD |
-0.65
|
$25.23M 27.58M USD | $1K 1.09K USD | $0.46 0.5 USD | $0.46 0.5 USD | $25.23M 27.58M USD | 0 | -$0.05 -0.05 USD | |
Active Biotech AB (publ) BTPC.F | $0.01 0.02 USD |
-7.55
|
$19.57M 21.39M USD | $50K 54.66K USD | $0.01 0.02 USD | $0.01 0.02 USD | $19.57M 21.39M USD | 0 | -$0.01 -0.01 USD | |
BioVaxys Technology Corp. 5LB.F | $0.01 0.01 USD |
0
|
$6.41M 7.01M USD | $23K 25.14K USD | $0.01 0.01 USD | $0.01 0.01 USD | $6.41M 7.01M USD | 0 | -$0.01 -0.01 USD | |
Glow Lifetech Corp. 9DO.F | $0.02 0.02 USD |
+13.16
|
$6M 6.56M USD | $4.1K 4.49K USD | $0.02 0.02 USD | $0.02 0.02 USD | $6M 6.56M USD | 0 | -$0.02 -0.02 USD | |
Memphasys Limited IG7.F | $0.002 0.0021 USD |
0
|
$5.54M 6.05M USD | $364.25K 398.17K USD | $0.002 0.0021 USD | $0.0035 0.0038 USD | $5.54M 6.05M USD | 0 | $0 0 USD | |
Medigene AG MDG1.F | $0.13 0.14 USD |
+3.73
|
$2.04M 2.23M USD | $15 16.4 USD | $0.13 0.14 USD | $0.13 0.14 USD | $2.04M 2.23M USD | 0 | -$1.21 -1.3 USD | |
BioSenic S.A. BT1.F | $0.0022 0.0024 USD |
-15.38
|
$1.44M 1.57M USD | $15.5K 16.94K USD | $0.0022 0.0024 USD | $0.0022 0.0024 USD | $1.44M 1.57M USD | 0 | -$0.04 -0.04 USD | |
Novo Nordisk A/S NOVA.F | $58.3 63.73 USD |
+1.92
|
$261.58B 285.95B USD | $200 218.63 USD | $58 63.4 USD | $58.3 63.73 USD | $261.58B 285.95B USD | 18.50 | $3.15 3.44 USD | |
Vertex Pharmaceuticals Incorporated VX1.F | $376.5 411.57 USD |
-1
|
$96.68B 105.69B USD | $68 74.33 USD | $376.5 411.57 USD | $376.95 412.06 USD | $96.68B 105.69B USD | 0 | -$3.27 -3.5 USD | |
CSL Limited CSJ.F | $130.32 142.46 USD |
-2.48
|
$63.53B 69.45B USD | $5 5.47 USD | $130.32 142.46 USD | $130.32 142.46 USD | $63.53B 69.45B USD | 27.96 | $4.66 5.09 USD | |
CSL Limited CSJA.F | $64.5 70.51 USD |
-2.27
|
$63.39B 69.3B USD | $5 5.47 USD | $64.5 70.51 USD | $64.5 70.51 USD | $63.39B 69.3B USD | 27.68 | $2.33 2.55 USD | |
Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
Alnylam Pharmaceuticals, Inc. DUL.F | $270.2 295.37 USD |
-1.24
|
$35.23B 38.51B USD | $10 10.93 USD | $270.2 295.37 USD | $270.2 295.37 USD | $35.23B 38.51B USD | 0 | -$1.81 -1.9 USD | |
UCB SA UNC.F | $171.1 187.04 USD |
+1.24
|
$32.52B 35.54B USD | $310 338.87 USD | $171.1 187.04 USD | $171.1 187.04 USD | $32.52B 35.54B USD | 31.22 | $5.48 5.99 USD | |
UCB SA UNC0.F | $84.5 92.37 USD |
+1.2
|
$32.48B 35.51B USD | $50 54.66 USD | $84.5 92.37 USD | $84.5 92.37 USD | $32.48B 35.51B USD | 30.83 | $2.74 3 USD | |
argenx SE 1AEA.F | $474 518.15 USD |
0
|
$29.5B 32.25B USD | $12 13.12 USD | $474 518.15 USD | $474 518.15 USD | $29.5B 32.25B USD | 33.78 | $14.03 15.34 USD | |
argenx SE 1AE.F | $478.3 522.85 USD |
-0.23
|
$29.43B 32.17B USD | $2 2.19 USD | $478.3 522.85 USD | $478.3 522.85 USD | $29.43B 32.17B USD | 34.04 | $14.05 15.36 USD | |
BeOne Medicines Ltd. 49B.F | $16.6 18.15 USD |
0
|
$25.73B 28.13B USD | $0 0 USD | $0 0 USD | $0 0 USD | $25.73B 28.13B USD | 0 | $0 0 USD | |
BeOne Medicines Ltd. 49BA.F | $212 231.74 USD |
-5.36
|
$24.95B 27.27B USD | $6 6.56 USD | $212 231.74 USD | $212 231.74 USD | $24.95B 27.27B USD | 0 | -$3.11 -3.3 USD | |
BioNTech SE 22UA.F | $90.55 98.98 USD |
+1.06
|
$22.07B 24.13B USD | $133 145.39 USD | $90.4 98.82 USD | $91.35 99.86 USD | $22.07B 24.13B USD | 0 | -$3.19 -3.4 USD | |
Royalty Pharma plc RPD.F | $29.47 32.21 USD |
-2.93
|
$16.48B 18.01B USD | $150 163.97 USD | $29.47 32.21 USD | $29.47 32.21 USD | $16.48B 18.01B USD | 14.03 | $2.1 2.3 USD | |
Insmed Incorporated IM8N.F | $86.5 94.56 USD |
-2.81
|
$16.43B 17.96B USD | $88 96.2 USD | $86.5 94.56 USD | $86.5 94.56 USD | $16.43B 17.96B USD | 0 | -$5.07 -5.5 USD | |
Innovent Biologics, Inc. 6IB.F | $8.3 9.07 USD |
-1.19
|
$13.87B 15.17B USD | $200 218.63 USD | $8.3 9.07 USD | $8.55 9.35 USD | $13.87B 15.17B USD | 0 | -$0.01 -0.01 USD | |
Incyte Corporation ICY.F | $60.32 65.94 USD |
+4.72
|
$12.29B 13.43B USD | $1.36K 1.49K USD | $60.32 65.94 USD | $60.32 65.94 USD | $12.29B 13.43B USD | 354.82 | $0.17 0.19 USD | |
WuXi Biologics (Cayman) Inc. 1FW1.F | $5.3 5.79 USD |
0
|
$11.09B 12.13B USD | $208 227.37 USD | $5.5 6.01 USD | $5.5 6.01 USD | $11.09B 12.13B USD | 27.89 | $0.19 0.21 USD | |
United Therapeutics Corporation UTH.F | $241.7 264.21 USD |
-0.9
|
$10.9B 11.92B USD | $80 87.45 USD | $241.7 264.21 USD | $241.7 264.21 USD | $10.9B 11.92B USD | 11.24 | $21.49 23.49 USD | |
WuXi Biologics (Cayman) Inc. 1FW2.F | $2.67 2.92 USD |
-1.84
|
$10.89B 11.9B USD | $2K 2.19K USD | $2.67 2.92 USD | $2.67 2.92 USD | $10.89B 11.9B USD | 29.66 | $0.09 0.1 USD | |
Verona Pharma plc I9SA.F | $83.4 91.17 USD |
0
|
$10.76B 11.77B USD | $72 78.71 USD | $81.8 89.42 USD | $85.8 93.79 USD | $10.76B 11.77B USD | 0 | -$1.71 -1.8 USD | |
Exelixis, Inc. EX9.F | $36.53 39.93 USD |
-1.06
|
$9.96B 10.89B USD | $100 109.31 USD | $36.53 39.93 USD | $36.53 39.93 USD | $9.96B 10.89B USD | 19.43 | $1.88 2.06 USD | |
Moderna, Inc. 0QF.F | $23.95 26.18 USD |
+5.18
|
$9.59B 10.48B USD | $60 65.59 USD | $23.5 25.69 USD | $23.95 26.18 USD | $9.59B 10.48B USD | 0 | -$7.47 -8.1 USD | |
Akeso, Inc. 4RY.F | $9.9 10.82 USD |
-1.98
|
$9.1B 9.95B USD | $84 91.82 USD | $9.8 10.71 USD | $9.9 10.82 USD | $9.1B 9.95B USD | 0 | -$0.07 -0.07 USD | |
Ascendis Pharma A/S A71.F | $147 160.69 USD |
0
|
$8.96B 9.79B USD | $1 1.09 USD | $153 167.25 USD | $153 167.25 USD | $8.96B 9.79B USD | 0 | -$5.81 -6.3 USD | |
BioMarin Pharmaceutical Inc. BM8.F | $46.1 50.39 USD |
-0.11
|
$8.87B 9.7B USD | $12 13.12 USD | $46.1 50.39 USD | $46.1 50.39 USD | $8.87B 9.7B USD | 19.95 | $2.31 2.53 USD | |
ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
BridgeBio Pharma, Inc. 2CL.F | $38.33 41.9 USD |
+2.46
|
$7.51B 8.21B USD | $25 27.33 USD | $38.33 41.9 USD | $38.33 41.9 USD | $7.51B 8.21B USD | 0 | -$3.05 -3.3 USD | |
Blueprint Medicines Corporation 2L9.F | $109.1 119.26 USD |
+1.11
|
$7.17B 7.84B USD | $135 147.57 USD | $109.1 119.26 USD | $109.1 119.26 USD | $7.17B 7.84B USD | 0 | -$2.15 -2.3 USD | |
Bio-Techne Corporation TE1.F | $44.6 48.75 USD |
+0.45
|
$7.12B 7.78B USD | $50 54.66 USD | $44.6 48.75 USD | $44.6 48.75 USD | $7.12B 7.78B USD | 62.81 | $0.71 0.78 USD | |
Roivant Sciences Ltd. 87S.F | $9.8 10.71 USD |
+2.72
|
$6.93B 7.58B USD | $600 655.88 USD | $9.8 10.71 USD | $9.81 10.72 USD | $6.93B 7.58B USD | 0 | -$0.64 -0.6 USD | |
Corcept Therapeutics Incorporated HTD.F | $63.04 68.91 USD |
+1.06
|
$6.82B 7.45B USD | $11 12.02 USD | $63.04 68.91 USD | $63.04 68.91 USD | $6.82B 7.45B USD | 63.67 | $0.99 1.08 USD | |
Sirius XM Holdings Inc. R 3HY.F | $18.9 20.66 USD |
0
|
$6.51B 7.12B USD | $106 115.87 USD | $18.9 20.66 USD | $18.9 20.66 USD | $6.51B 7.12B USD | 0 | -$4.32 -4.7 USD | |
Financière de Tubize SA FTD.F | $133.2 145.61 USD |
+0.45
|
$6.03B 6.59B USD | $70 76.52 USD | $133.2 145.61 USD | $133.2 145.61 USD | $6.03B 6.59B USD | 65.61 | $2.03 2.22 USD | |
Revolution Medicines, Inc. 42Z.F | $31.6 34.54 USD |
-3.07
|
$5.89B 6.43B USD | $16 17.49 USD | $31.6 34.54 USD | $31.6 34.54 USD | $5.89B 6.43B USD | 0 | -$3.43 -3.7 USD | |
3SBio Inc. 83B.F | $2.44 2.67 USD |
+2.52
|
$5.78B 6.32B USD | $3.97K 4.34K USD | $2.32 2.54 USD | $2.44 2.67 USD | $5.78B 6.32B USD | 24.39 | $0.1 0.11 USD | |
Madrigal Pharmaceuticals, Inc. YDO1.F | $254.2 277.87 USD |
-0.31
|
$5.67B 6.2B USD | $17 18.58 USD | $254.2 277.87 USD | $254.2 277.87 USD | $5.67B 6.2B USD | 0 | -$15.26 -16.6 USD | |
Halozyme Therapeutics, Inc. RV7.F | $44.88 49.06 USD |
+0.36
|
$5.56B 6.08B USD | $20 21.86 USD | $44.88 49.06 USD | $44.88 49.06 USD | $5.56B 6.08B USD | 13.93 | $3.22 3.52 USD | |
Jazz Pharmaceuticals plc J7Z.F | $91 99.48 USD |
-0.5
|
$5.54B 6.06B USD | $6 6.56 USD | $91 99.48 USD | $91 99.48 USD | $5.54B 6.06B USD | 14.44 | $6.3 6.89 USD | |
ALK-Abelló A/S 4AJ0.F | $24.98 27.31 USD |
+0.08
|
$5.49B 6B USD | $2 2.19 USD | $24.72 27.02 USD | $24.98 27.31 USD | $5.49B 6B USD | 44.60 | $0.56 0.61 USD | |
Ionis Pharmaceuticals, Inc. ISI.F | $33.83 36.98 USD |
-0.59
|
$5.39B 5.89B USD | $235 256.89 USD | $33.83 36.98 USD | $33.83 36.98 USD | $5.39B 5.89B USD | 0 | -$2.56 -2.7 USD | |
Legend Biotech Corporation 9LB.F | $28.4 31.05 USD |
+1.43
|
$5.35B 5.85B USD | $120 131.18 USD | $28.4 31.05 USD | $28.4 31.05 USD | $5.35B 5.85B USD | 0 | -$1.01 -1.1 USD | |
TG Therapeutics, Inc. NKB2.F | $32.13 35.12 USD |
+1.85
|
$5.25B 5.74B USD | $50 54.66 USD | $32.13 35.12 USD | $32.13 35.12 USD | $5.25B 5.74B USD | 153.00 | $0.21 0.23 USD | |
Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
Axsome Therapeutics, Inc. 19X.F | $86.78 94.86 USD |
-1.07
|
$4.28B 4.67B USD | $23 25.14 USD | $86.78 94.86 USD | $86.78 94.86 USD | $4.28B 4.67B USD | 0 | -$4.94 -5.4 USD | |
Alpine Immune Sciences, Inc. 34LA.F | $59 64.49 USD |
0
|
$4.1B 4.48B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.1B 4.48B USD | 0 | $0 0 USD | |
Akero Therapeutics, Inc. 0K4.F | $47.97 52.44 USD |
+2.15
|
$3.92B 4.29B USD | $150 163.97 USD | $47.97 52.44 USD | $47.97 52.44 USD | $3.92B 4.29B USD | 0 | -$3.21 -3.5 USD | |
Mirati Therapeutics, Inc. 26M.F | $53.3 58.26 USD |
0
|
$3.79B 4.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.79B 4.14B USD | 0 | $0 0 USD | |
Vaxcyte, Inc. 5VA.F | $26.8 29.3 USD |
-0.74
|
$3.6B 3.94B USD | $280 306.08 USD | $26.8 29.3 USD | $26.8 29.3 USD | $3.6B 3.94B USD | 0 | -$3.42 -3.7 USD | |
Krystal Biotech, Inc. 4KB.F | $121.2 132.49 USD |
+0.08
|
$3.53B 3.86B USD | $190 207.7 USD | $121.2 132.49 USD | $121.2 132.49 USD | $3.53B 3.86B USD | 33.94 | $3.57 3.9 USD | |
Cytokinetics, Incorporated KK3A.F | $28.8 31.48 USD |
+1.41
|
$3.52B 3.84B USD | $150 163.97 USD | $28.8 31.48 USD | $28.8 31.48 USD | $3.52B 3.84B USD | 0 | -$4.53 -4.9 USD | |
Genscript Biotech Corporation G51.F | $1.54 1.69 USD |
+0.92
|
$3.49B 3.81B USD | $2.77K 3.03K USD | $1.54 1.69 USD | $1.54 1.69 USD | $3.49B 3.81B USD | 0 | -$0.07 -0.07 USD | |
CymaBay Therapeutics, Inc. C0I.F | $29.8 32.58 USD |
0
|
$3.43B 3.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.43B 3.75B USD | 0 | $0 0 USD | |
Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | $7.8 8.53 USD |
+1.3
|
$3.41B 3.73B USD | $971 1.06K USD | $7.8 8.53 USD | $7.8 8.53 USD | $3.41B 3.73B USD | 22.94 | $0.34 0.37 USD | |
Rhythm Pharmaceuticals, Inc. 1RV.F | $52.5 57.39 USD |
+0.96
|
$3.38B 3.69B USD | $20 21.86 USD | $52.5 57.39 USD | $52.5 57.39 USD | $3.38B 3.69B USD | 0 | -$2.4 -2.6 USD | |
Zai Lab Limited 1ZL.F | $29.6 32.36 USD |
-3.27
|
$3.34B 3.65B USD | $230 251.42 USD | $29.6 32.36 USD | $29.6 32.36 USD | $3.34B 3.65B USD | 0 | -$2.14 -2.3 USD | |
Merus N.V. 2GH.F | $44.2 48.32 USD |
-1.78
|
$3.33B 3.64B USD | $106 115.87 USD | $44.2 48.32 USD | $44.2 48.32 USD | $3.33B 3.64B USD | 0 | -$3.56 -3.8 USD | |
ACADIA Pharmaceuticals Inc. DR6.F | $18.88 20.63 USD |
-1.33
|
$3.16B 3.45B USD | $100 109.31 USD | $18.88 20.63 USD | $18.88 20.63 USD | $3.16B 3.45B USD | 16.13 | $1.17 1.28 USD | |
Camurus AB (publ) 7CA.F | $53.35 58.32 USD |
-0.28
|
$3.14B 3.43B USD | $18 19.68 USD | $53.35 58.32 USD | $53.35 58.32 USD | $3.14B 3.43B USD | 64.27 | $0.83 0.91 USD | |
Ultragenyx Pharmaceutical Inc. UP0.F | $31.6 34.54 USD |
-0.63
|
$2.99B 3.27B USD | $48 52.47 USD | $31.6 34.54 USD | $31.6 34.54 USD | $2.99B 3.27B USD | 0 | -$4.99 -5.4 USD | |
Ascentage Pharma Group International 36X.F | $8.3 9.07 USD |
-2.35
|
$2.94B 3.22B USD | $174 190.21 USD | $8.25 9.02 USD | $8.3 9.07 USD | $2.94B 3.22B USD | 0 | -$0.16 -0.1 USD | |
Scholar Rock Holding Corporation 2QK.F | $30 32.79 USD |
-1.32
|
$2.85B 3.11B USD | $50 54.66 USD | $30 32.79 USD | $30 32.79 USD | $2.85B 3.11B USD | 0 | -$2.18 -2.3 USD | |
Laboratorios Farmaceuticos Rovi, S.A. 41L.F | $54.4 59.47 USD |
+1.49
|
$2.82B 3.08B USD | $75 81.99 USD | $54.4 59.47 USD | $54.4 59.47 USD | $2.82B 3.08B USD | 19.92 | $2.73 2.98 USD | |
Viking Therapeutics, Inc. 1VT.F | $24.9 27.22 USD |
+1.9
|
$2.8B 3.06B USD | $1K 1.09K USD | $24.9 27.22 USD | $24.9 27.22 USD | $2.8B 3.06B USD | 0 | -$0.99 -1.08 USD | |
MorphoSys AG MOR2.F | $16.8 18.36 USD |
0
|
$2.61B 2.85B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.61B 2.85B USD | 0 | $0 0 USD | |
Morphic Holding, Inc. 31Y.F | $50 54.66 USD |
0
|
$2.6B 2.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.6B 2.84B USD | 0 | $0 0 USD | |
MorphoSys AG MOR.F | $67.8 74.11 USD |
0
|
$2.55B 2.79B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.55B 2.79B USD | 0 | $0 0 USD | |
Crinetics Pharmaceuticals, Inc. 6Z4.F | $25.6 27.98 USD |
-1.54
|
$2.4B 2.62B USD | $60 65.59 USD | $25.6 27.98 USD | $25.6 27.98 USD | $2.4B 2.62B USD | 0 | -$3.25 -3.5 USD | |
Catalyst Pharmaceuticals, Inc. CN2.F | $18.57 20.29 USD |
+3.14
|
$2.36B 2.58B USD | $219 239.4 USD | $18.57 20.29 USD | $18.57 20.29 USD | $2.36B 2.58B USD | 13.85 | $1.34 1.46 USD | |
Mirum Pharmaceuticals, Inc. 08D.F | $42 45.91 USD |
+0.48
|
$2.15B 2.35B USD | $26 28.42 USD | $41.8 45.69 USD | $42 45.91 USD | $2.15B 2.35B USD | 0 | -$1.38 -1.5 USD | |
Xenon Pharmaceuticals Inc. XP0.F | $27.4 29.95 USD |
+0.74
|
$2.13B 2.33B USD | $10 10.93 USD | $27.4 29.95 USD | $27.4 29.95 USD | $2.13B 2.33B USD | 0 | -$2.76 -3.01 USD | |
ImmunityBio, Inc. 26CA.F | $2.36 2.58 USD |
-0.04
|
$2.11B 2.3B USD | $196 214.25 USD | $2.36 2.58 USD | $2.36 2.58 USD | $2.11B 2.3B USD | 0 | -$0.49 -0.5 USD | |
Everest Medicines Limited 6HN.F | $5.95 6.5 USD |
0
|
$1.99B 2.17B USD | $12 13.12 USD | $5.9 6.45 USD | $5.9 6.45 USD | $1.99B 2.17B USD | 0 | -$0.39 -0.4 USD | |
Apellis Pharmaceuticals, Inc. 1JK.F | $15.07 16.48 USD |
+0.07
|
$1.98B 2.17B USD | $680 743.33 USD | $15.07 16.48 USD | $15.07 16.48 USD | $1.98B 2.17B USD | 0 | -$1.54 -1.6 USD | |
Ligand Pharmaceuticals Incorporated LGDN.F | $99 108.22 USD |
+2.06
|
$1.95B 2.13B USD | $20 21.86 USD | $99 108.22 USD | $99 108.22 USD | $1.95B 2.13B USD | 0 | -$6.24 -6.8 USD | |
Arrowhead Pharmaceuticals, Inc. HDP1.F | $13.67 14.94 USD |
+2.55
|
$1.95B 2.13B USD | $80 87.45 USD | $13.67 14.94 USD | $13.67 14.94 USD | $1.95B 2.13B USD | 0 | -$1.06 -1.1 USD | |
Veracyte, Inc. 12V.F | $22.8 24.92 USD |
+1.79
|
$1.83B 2B USD | $250 273.28 USD | $22.8 24.92 USD | $22.8 24.92 USD | $1.83B 2B USD | 63.33 | $0.36 0.39 USD | |
Denali Therapeutics Inc. 4DN.F | $12.33 13.48 USD |
+0.24
|
$1.81B 1.97B USD | $200 218.63 USD | $12.33 13.48 USD | $12.33 13.48 USD | $1.81B 1.97B USD | 0 | -$2.29 -2.5 USD | |
BB Biotech AG BBZA.F | $32.85 35.91 USD |
+1.55
|
$1.8B 1.97B USD | $250 273.28 USD | $32 34.98 USD | $32.85 35.91 USD | $1.8B 1.97B USD | 13.46 | $2.44 2.67 USD | |
Vericel Corporation ATQP.F | $35.4 38.7 USD |
-0.56
|
$1.79B 1.95B USD | $52 56.84 USD | $35.4 38.7 USD | $35.4 38.7 USD | $1.79B 1.95B USD | 885.00 | $0.04 0.04 USD | |
Bavarian Nordic A/S BV3.F | $22.21 24.28 USD |
+0.05
|
$1.78B 1.95B USD | $159 173.81 USD | $22.21 24.28 USD | $22.21 24.28 USD | $1.78B 1.95B USD | 9.87 | $2.25 2.46 USD | |
Agios Pharmaceuticals, Inc. 8AP.F | $28.6 31.26 USD |
+2.88
|
$1.72B 1.88B USD | $54 59.03 USD | $28.6 31.26 USD | $28.6 31.26 USD | $1.72B 1.88B USD | 2.89 | $9.88 10.8 USD | |
BioCryst Pharmaceuticals, Inc. BO1.F | $8.18 8.95 USD |
-0.82
|
$1.72B 1.88B USD | $100 109.31 USD | $8.18 8.95 USD | $8.18 8.95 USD | $1.72B 1.88B USD | 0 | -$0.22 -0.2 USD | |
IDEAYA Biosciences, Inc. 30J.F | $19 20.77 USD |
+1.6
|
$1.7B 1.86B USD | $350 382.6 USD | $19 20.77 USD | $19 20.77 USD | $1.7B 1.86B USD | 0 | -$3.12 -3.4 USD | |
Adaptive Biotechnologies Corporation 1HM.F | $10.27 11.23 USD |
+0.98
|
$1.6B 1.75B USD | $10 10.93 USD | $10.27 11.23 USD | $10.27 11.23 USD | $1.6B 1.75B USD | 0 | -$0.81 -0.8 USD | |
Galapagos NV GXEA.F | $23.8 26.02 USD |
+0.85
|
$1.59B 1.73B USD | $2 2.19 USD | $23.8 26.02 USD | $23.8 26.02 USD | $1.59B 1.73B USD | 0 | -$2.73 -2.9 USD | |
お気に入り銘柄なし
お気に入りの株式はまだありません。ここで表示するにはお気に入りに追加してください |